EXXOGEN is an R&D-based biotechnology startup working on redefining molecular recognition and interactions. Powered by a proprietary quantum physics equation.
EXXOGEN is an R&D-based biotechnology startup working on redefining molecular recognition and interactions. Powered by a proprietary quantum physics equation.
Core Breakthrough: Formulated a proprietary, closed-form quantum physics equation that solves complex many-body problems analytically (solving limitations of the Schrödinger equation without relying on resource-intensive DFT approximations or supercomputing clusters).
1D66 GAL4–DNA
Experimental Validation: Benchmark testing against the 1D66 GAL4–DNA complex structure demonstrated 100% structural alignment and exact energy state/electron density mapping matching published experimental literature.
Biomolecular Applications: Applied to metagenomic alpha-helix structures (e.g., ESMAtlas MGYP001563787740), uncovering room-temperature quantum coherence, spatial chirality waves, and radiation-resistant salt-bridge networks.
MGYP001563787740
Automated database generation from hundreds or thousands of self-calculated data points.
Target Markets: Next-generation drug discovery (All images are genuine and come from Exxogen analyses), radiation-hardened space electronics, ultra-low-power bio-semiconductors, and rational enzyme engineering.
Current Stage: Early-stage DeepTech R&D / Analytical framework validated. Seeking strategic R&D partnerships, academic/industrial testing collaborations, and pre-seed/seed investors in DeepTech, Quantum Chemistry, and Biotech.
1AON
"We don't search databases - we calculate reality."
1AON SIDE VIEW